NVO — Novo Nordisk A/S

Healthcare · Drug Manufacturers - General · NYSE

$48.61

Market Cap: $216.0B

Key Fundamentals

P/E Ratio

2.2

P/B Ratio

1.1

Return on Equity

61.1%

Net Profit Margin

31.9%

Revenue Growth

2.3%

Dividend Yield

24.0%

Debt / Equity

0.7

EPS (TTM)

$22.16

Piotroski F-Score

8/9

Beta

0.27

About Novo Nordisk A/S

Novo Nordisk A/S (ticker: NVO, listed on NYSE) is a company in the Healthcare · Drug Manufacturers - General sector with a market capitalization of $216.0B.

This page shows publicly available fundamental data for NVO sourced from Valory's database of 36,000+ US stocks. For deeper analysis — including Valory Formula projected returns, historical financials, and analyst consensus — create a free account.

Data is updated regularly during US market hours. Fundamental data is sourced from public filings and market data providers. This page is for informational purposes only and does not constitute investment advice.